Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
J Immunol
    May 2024
  1. DAI YD, Du W, Wang Y, Hu WY, et al
    A Targeted Deep Sequencing Method to Quantify Endogenous Retrovirus Gag Sequence Variants and Open Reading Frames Expressed in Nonobese Diabetic Mice.
    J Immunol. 2024 May 13:ji2300660. doi: 10.4049/jimmunol.2300660.
    >> Share

    April 2024
  2. DE GEORGE DJ, Jhala G, Selck C, Trivedi P, et al
    Altering beta Cell Antigen Exposure to Exhausted CD8+ T Cells Prevents Autoimmune Diabetes in Mice.
    J Immunol. 2024 Apr 8:ji2300785. doi: 10.4049/jimmunol.2300785.
    >> Share

    March 2024
  3. RACINE JJ, Bachman JF, Zhang JG, Misherghi A, et al
    Murine MHC-Deficient Nonobese Diabetic Mice Carrying Human HLA-DQ8 Develop Severe Myocarditis and Myositis in Response to Anti-PD-1 Immune Checkpoint Inhibitor Cancer Therapy.
    J Immunol. 2024 Mar 1:ji2300841. doi: 10.4049/jimmunol.2300841.
    >> Share

  4. COSTANZO A, Clarke D, Holt M, Sharma S, et al
    Repositioning the Early Pathology of Type 1 Diabetes to the Extraislet Vasculature.
    J Immunol. 2024 Mar 1:ji2300769. doi: 10.4049/jimmunol.2300769.
    >> Share

    January 2024
  5. KLUG N, Burke J, Scott E
    Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.
    J Immunol. 2024;212:216-224.
    >> Share

    December 2023
  6. FOER D, Amin T, Nagai J, Tani Y, et al
    Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease.
    J Immunol. 2023;211:1806-1813.
    >> Share

    October 2023
  7. RACINE JJ, Misherghi A, Dwyer JR, Maser R, et al
    HLA-DQ8 Supports Development of Insulitis Mediated by Insulin-Reactive Human TCR-Transgenic T Cells in Nonobese Diabetic Mice.
    J Immunol. 2023 Oct 25:ji2300303. doi: 10.4049/jimmunol.2300303.
    >> Share

  8. GILLES A, Hu L, Virdis F, Sant'Angelo DB, et al
    The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
    J Immunol. 2023 Oct 9:ji2300213. doi: 10.4049/jimmunol.2300213.
    >> Share

    September 2023
  9. NEW JS, Dizon BLP, King RG, Greenspan NS, et al
    B-1 B Cell-Derived Natural Antibodies against N-Acetyl-d-Glucosamine Suppress Autoimmune Diabetes Pathogenesis.
    J Immunol. 2023 Sep 25:ji2300264. doi: 10.4049/jimmunol.2300264.
    >> Share

    May 2023
  10. WU F, Wei H, Hu Y, Gao J, et al
    Upregulation of P2X7 Exacerbates Myocardial Ischemia-Reperfusion Injury through Enhancing Inflammation and Apoptosis in Diabetic Mice.
    J Immunol. 2023 May 5:ji2200838. doi: 10.4049/jimmunol.2200838.
    >> Share

    March 2023
  11. ZHANG X, Ohayon-Steckel L, Coppin E, Johny E, et al
    Epidermal Growth Factor Receptor in Hepatic Endothelial Cells Suppresses MCP-1-Dependent Monocyte Recruitment in Diabetes.
    J Immunol. 2023 Mar 22:ji2200557. doi: 10.4049/jimmunol.2200557.
    >> Share

    February 2023
  12. CIECKO AE, Wang Y, Harleston S, Drewek A, et al
    Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes.
    J Immunol. 2023 Feb 10:ji2200712. doi: 10.4049/jimmunol.2200712.
    >> Share

    January 2023
  13. REYES J, Yap GS
    Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis.
    J Immunol. 2023;210:5-11.
    >> Share

    June 2022
  14. DWYER JR, Racine JJ, Chapman HD, Quinlan A, et al
    Nfkbid Overexpression in Nonobese Diabetic Mice Elicits Complete Type 1 Diabetes Resistance in Part Associated with Enhanced Thymic Deletion of Pathogenic CD8 T Cells and Increased Numbers and Activity of Regulatory T Cells.
    J Immunol. 2022 Jun 27. pii: jimmunol.2100558. doi: 10.4049/jimmunol.2100558.
    >> Share

  15. PODOJIL JR, Genardi S, Chiang MY, Kakade S, et al
    Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic beta Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic Mice.
    J Immunol. 2022 Jun 20. pii: jimmunol.2200208. doi: 10.4049/jimmunol.2200208.
    >> Share

    March 2022
  16. BEN NASR M, Robbins D, Parone P, Usuelli V, et al
    Pharmacologically Enhanced Regulatory Hematopoietic Stem Cells Revert Experimental Autoimmune Diabetes and Mitigate Other Autoimmune Disorders.
    J Immunol. 2022 Mar 23. pii: jimmunol.2100949. doi: 10.4049/jimmunol.2100949.
    >> Share

  17. MELLANBY RJ, Koonce CH, Monti A, Phillips JM, et al
    Correction: Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes.
    J Immunol. 2022 Mar 2. pii: jimmunol.2200006. doi: 10.4049/jimmunol.2200006.
    >> Share

  18. MAO QY, He SY, Hu QY, Lu Y, et al
    Advanced Glycation End Products (AGEs) Inhibit Macrophage Efferocytosis of Apoptotic beta Cells through Binding to the Receptor for AGEs.
    J Immunol. 2022;208:1204-1213.
    >> Share

    February 2022
  19. JIANG R, Qin Y, Wang Y, Xu X, et al
    Dynamic Number and Function of IL-10-Producing Regulatory B Cells in the Immune Microenvironment at Distinct Stages of Type 1 Diabetes.
    J Immunol. 2022 Feb 9. pii: jimmunol.2100357. doi: 10.4049/jimmunol.2100357.
    >> Share

    January 2022
  20. LOMBARD-VADNAIS F, Collin R, Daudelin JF, Chabot-Roy G, et al
    The Idd2 Locus Confers Prominent Resistance to Autoimmune Diabetes.
    J Immunol. 2022 Jan 17. pii: jimmunol.2100456. doi: 10.4049/jimmunol.2100456.
    >> Share

  21. JONES BE, Maerz MD, Bahnson HT, Somasundaram A, et al
    Fewer LAG-3(+) T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 Diabetes.
    J Immunol. 2022 Jan 12. pii: jimmunol.2100850. doi: 10.4049/jimmunol.2100850.
    >> Share

    October 2021
  22. LI M, Itoh A, Xi J, Yu C, et al
    Enhancing Antigen Presentation and Inducing Antigen-Specific Immune Tolerance with Amphiphilic Peptides.
    J Immunol. 2021;207:2051-2059.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016